{"id":578878,"date":"2025-06-09T20:46:20","date_gmt":"2025-06-10T03:46:20","guid":{"rendered":"https:\/\/nai500.com\/?p=578878"},"modified":"2025-06-09T20:49:06","modified_gmt":"2025-06-10T03:49:06","slug":"%e5%8c%bb%e7%96%97%e8%a1%8c%e4%b8%9a%e5%b8%82%e5%80%bc%e5%8d%81%e5%bc%ba%e5%87%ba%e7%82%89-%e5%88%b6%e8%8d%af%e5%b7%a8%e5%a4%b4-%e7%a4%bc%e6%9d%a5","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2025\/06\/%e5%8c%bb%e7%96%97%e8%a1%8c%e4%b8%9a%e5%b8%82%e5%80%bc%e5%8d%81%e5%bc%ba%e5%87%ba%e7%82%89-%e5%88%b6%e8%8d%af%e5%b7%a8%e5%a4%b4-%e7%a4%bc%e6%9d%a5\/","title":{"rendered":"\u533b\u7597\u884c\u4e1a\u5e02\u503c\u5341\u5f3a\u51fa\u7089\uff1a\u5236\u836f\u5de8\u5934\u4e3b\u5bfc\uff0c\u793c\u6765\u9886\u8dd1"},"content":{"rendered":"

\u6839\u636e\u6700\u65b0\u5e02\u573a\u6570\u636e\uff0c\u793c\u6765\u3001\u5f3a\u751f\u548c\u827e\u4f2f\u7ef4\u4f4d\u5c45\u5168\u7403\u533b\u7597\u5065\u5eb7\u9886\u57df\u5e02\u503c\u524d\u4e09\u7532\u3002\u5236\u836f\u4f01\u4e1a\u5728\u8be5\u9886\u57df\u5360\u636e\u4e3b\u5bfc\u5730\u4f4d\uff0c\u5728\u5e02\u503c\u6700\u5927\u7684\u533b\u7597\u80a1\u7968\u4e2d\u5360\u6bd4\u8fc7\u534a\u3002<\/p>\n

\u8fd9\u5341\u5927\u533b\u7597\u80a1\u7968\u5f53\u4e2d\uff0c\u8fc7\u53bb\u4e94\u5e74\u4ec5\u6709\u56db\u5bb6\u8868\u73b0\u4f18\u4e8e\u6807\u666e500\u6307\u6570\u3002\u6b64\u5916\uff0c\u8be5\u884c\u4e1a\u8fd8\u9762\u4e34\u65b0\u4ea7\u54c1\u5f00\u53d1\u548c\u5ba1\u6279\u6d41\u7a0b\u6f2b\u957f\u7b49\u7279\u6709\u98ce\u9669\uff0c\u540c\u65f6\u7279\u6717\u666e\u7684\u8fdb\u53e3\u5173\u7a0e\u53ef\u80fd\u63a8\u9ad8\u836f\u54c1\u548c\u533b\u7597\u8bbe\u5907\u7684\u6210\u672c\u3002\u5c3d\u7ba1\u5982\u6b64\uff0c\u533b\u7597\u5065\u5eb7\u7c7b\u80a1\u7968\u6ee1\u8db3\u7684\u662f\u521a\u9700\uff0c\u56e0\u6b64\u5f80\u5f80\u5177\u6709\u6297\u5e02\u573a\u4e0b\u884c\u7684\u80fd\u529b\uff0c\u4e00\u4e9b\u9876\u5c16\u7684\u533b\u7597\u5065\u5eb7\u516c\u53f8\u652f\u4ed8\u9ad8\u989d\u80a1\u606f\uff0c\u9002\u5408\u5bfb\u6c42\u6784\u5efa\u88ab\u52a8\u6536\u5165\u6d41\u7684\u6295\u8d44\u8005\u3002<\/p>\n

\u533b\u7597\u884c\u4e1a\u5e02\u503cTOP 10\uff08\u6570\u636e\u622a\u81f32025\u5e746\u67089\u65e5\uff09<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u6392\u540d<\/strong><\/td>\n\u516c\u53f8\u540d\u79f0 (\u80a1\u7968\u4ee3\u7801)<\/strong><\/td>\n\u5e02\u503c(6\/9)<\/strong><\/td>\n\u5f53\u524d\u80a1\u4ef7<\/strong><\/td>\n\u884c\u4e1a\u5206\u7c7b<\/strong><\/td>\n<\/tr>\n<\/thead>\n
1<\/td>\n\u793c\u6765 (LLY)<\/td>\n$7300\u4ebf<\/td>\n$776.10<\/td>\n\u5236\u836f<\/td>\n<\/tr>\n
2<\/td>\n\u5f3a\u751f (JNJ)<\/td>\n$3730\u4ebf<\/td>\n$155.90<\/td>\n\u5236\u836f<\/td>\n<\/tr>\n
3<\/td>\n\u827e\u4f2f\u7ef4 (ABBV)<\/td>\n$3350\u4ebf<\/td>\n$189.62<\/td>\n\u751f\u7269\u6280\u672f<\/td>\n<\/tr>\n
4<\/td>\n\u8054\u5408\u5065\u5eb7\u96c6\u56e2 (UNH)<\/td>\n$2750\u4ebf<\/td>\n$303.29<\/td>\n\u533b\u7597\u63d0\u4f9b\u5546\u548c\u670d\u52a1<\/td>\n<\/tr>\n
5<\/td>\n\u8bfa\u548c\u8bfa\u5fb7 (NVO)<\/td>\n$2510\u4ebf<\/td>\n$75.07<\/td>\n\u5236\u836f<\/td>\n<\/tr>\n
6<\/td>\n\u96c5\u57f9\u5b9e\u9a8c\u5ba4 (ABT)<\/td>\n$2320\u4ebf<\/td>\n$133.83<\/td>\n\u533b\u7597\u8bbe\u5907\u4e0e\u7528\u54c1<\/td>\n<\/tr>\n
7<\/td>\n\u963f\u65af\u5229\u5eb7 (AZN)<\/td>\n$2260\u4ebf<\/td>\n$73.47<\/td>\n\u5236\u836f<\/td>\n<\/tr>\n
8<\/td>\n\u8bfa\u534e (NVS)<\/td>\n$2240\u4ebf<\/td>\n$118.25<\/td>\n\u5236\u836f<\/td>\n<\/tr>\n
9<\/td>\nIntuitive Surgical (ISRG)<\/td>\n$2000\u4ebf<\/td>\n$525.61<\/td>\n\u533b\u7597\u8bbe\u5907\u4e0e\u7528\u54c1<\/td>\n<\/tr>\n
10<\/td>\n\u9ed8\u514b (MRK)<\/td>\n$1980\u4ebf<\/td>\n$79.17<\/td>\n\u5236\u836f<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u793c\u6765 (NYSE:LLY)<\/a><\/h2>\n
    \n
  • \u7b80\u4ecb\uff1a\u5168\u7403\u5e02\u503c\u6700\u9ad8\u7684\u5236\u836f\u516c\u53f8\uff0c\u7531\u4e00\u4f4d\u5316\u5b66\u5bb6\u53ca\u9000\u4f0d\u519b\u4eba\u4e8e1876\u5e74\u521b\u7acb\uff0c\u662f\u9996\u4e2a\u5927\u89c4\u6a21\u751f\u4ea7\u80f0\u5c9b\u7d20\u548c\u810a\u9ad3\u7070\u8d28\u708e\u75ab\u82d7\u7684\u516c\u53f8\u3002\u516c\u53f8\u6838\u5fc3\u4ea7\u54c1\u5305\u62ec\u7cd6\u5c3f\u75c5\u836f\u7269\u3001\u51cf\u80a5\u836f\u3001\u80a5\u80d6\u75c7\u6cbb\u7597\u836f\u7269\u53ca\u6297\u6291\u90c1\u836f\uff08\u5982\u767e\u5fe7\u89e3\uff09\u30022024\u5e74\uff0c\u793c\u6765\u4e0e\u4e9a\u9a6c\u900a(NASDAQ:AMZN)\u5408\u4f5c\u63d0\u4f9b\u836f\u7269\u9001\u8d27\u4e0a\u95e8\u670d\u52a1\u3002<\/li>\n
  • \u8865\u5145\u6570\u636e\uff08\u622a\u81f32025\u5e746\u67083\u65e5\uff0c\u4e0b\u540c\uff09\uff1a\u8425\u6536(TTM)490\u4ebf\u7f8e\u5143\uff1b\u6bdb\u5229\u6da6(TTM)400\u4ebf\u7f8e\u5143\uff1b\u4e94\u5e74\u5e74\u5316\u56de\u62a5\u738739.03%\u3002<\/li>\n<\/ul>\n

    \u5f3a\u751f (NYSE:JNJ)<\/h2>\n
      \n
    • \u7b80\u4ecb\uff1a\u4e1a\u52a1\u6db5\u76d6\u5236\u836f\u4e0e\u533b\u7597\u5668\u68b0\u3002\u4e3b\u8981\u90e8\u95e8\u5305\u62ec\u5f00\u53d1\u9500\u552e\u5904\u65b9\u836f\u7684\u521b\u65b0\u533b\u836f(Innovative Medicine)\u548c\u751f\u4ea7\u533b\u7597\u5668\u68b0\uff08\u5982ACUVUE\u9690\u5f62\u773c\u955c\uff09\u7684\u533b\u7597\u79d1\u6280(MedTech)\u30022023\u5e74\uff0c\u516c\u53f8\u5e9e\u5927\u7684\u6d88\u8d39\u8005\u5065\u5eb7\u90e8\u95e8\uff08\u751f\u4ea7\u6cf0\u8bfa\u3001\u90a6\u8fea\u7b49\u77e5\u540d\u4ea7\u54c1\uff09\u88ab\u5206\u62c6\u4e3a\u72ec\u7acb\u516c\u53f8Kenvue(NYSE:KVUE)\u3002<\/li>\n
    • \u8865\u5145\u6570\u636e\uff1a\u8425\u6536893\u4ebf\u7f8e\u5143\uff1b\u6bdb\u5229\u6da6610\u4ebf\u7f8e\u5143\uff1b\u4e94\u5e74\u5e74\u5316\u56de\u62a5\u73873.80%\u3002<\/li>\n<\/ul>\n

      \u827e\u4f2f\u7ef4 (NYSE:ABBV)<\/h2>\n
        \n
      • \u7b80\u4ecb\uff1a\u4e13\u6ce8\u4e8e\u5f00\u53d1\u6cbb\u7597\u4e25\u91cd\u75be\u75c5\u7684\u751f\u7269\u6280\u672f\u516c\u53f8\uff0c\u4ea7\u54c1\u6d89\u53ca\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u3001\u6591\u5757\u72b6\u94f6\u5c51\u75c5\u3001\u8840\u764c\u548c\u665a\u671f\u5e15\u91d1\u68ee\u75c5\u7b49\u9886\u57df\u3002\u8be5\u516c\u53f82012\u5e74\u4ece\u96c5\u57f9\u5b9e\u9a8c\u5ba4\u5206\u62c6\u6210\u7acb\uff0c\u662f\u533b\u7597\u5065\u5eb7\u677f\u5757\u7684\u4f18\u8d28\u80a1\u606f\u80a1\u4e4b\u4e00\uff0c\u5b9a\u671f\u63d0\u9ad8\u80a1\u606f\uff0c\u80a1\u606f\u6536\u76ca\u7387\u8f83\u9ad8\u3002<\/li>\n
      • \u8865\u5145\u6570\u636e\uff1a\u8425\u6536574\u4ebf\u7f8e\u5143\uff1b\u6bdb\u5229\u6da6444\u4ebf\u7f8e\u5143\uff1b\u4e94\u5e74\u5e74\u5316\u56de\u62a5\u738720.35%\u3002<\/li>\n<\/ul>\n

        \u8054\u5408\u5065\u5eb7\u96c6\u56e2 (NYSE:UNH)<\/h2>\n
          \n
        • \u7b80\u4ecb\uff1a\u901a\u8fc7UnitedHealthcare\u90e8\u95e8\u9500\u552e\u5065\u5eb7\u4fdd\u9669\u4ea7\u54c1\uff0c\u5e76\u901a\u8fc7Optum\u90e8\u95e8\u63d0\u4f9b\u533b\u7597\u670d\u52a1\u3002\u5c3d\u7ba1\u89c4\u6a21\u5e9e\u5927\uff0c\u4f46\u8fd1\u671f\u9762\u4e34\u6311\u6218\uff1a\u5b50\u516c\u53f8Change Healthcare\u53bb\u5e74\u53d1\u751f\u4e86\u53f2\u4e0a\u6700\u5927\u89c4\u6a21\u7684\u533b\u7597\u6570\u636e\u6cc4\u9732\u4e8b\u4ef6\uff1b\u9996\u5e2d\u6267\u884c\u5b98Andrew Witty\u4e8e\u4eca\u5e745\u6708\u56e0\u4e2a\u4eba\u539f\u56e0\u7a81\u7136\u8f9e\u804c\u3002<\/li>\n
        • \u8865\u5145\u6570\u636e\uff1a\u8425\u65364074\u4ebf\u7f8e\u5143\uff1b\u6bdb\u5229\u6da6875\u4ebf\u7f8e\u5143\uff1b\u4e94\u5e74\u5e74\u5316\u56de\u62a5\u73871.44%\u3002<\/li>\n<\/ul>\n

          \u8bfa\u548c\u8bfa\u5fb7 (NYSE:NVO)<\/h2>\n
            \n
          • \u7b80\u4ecb\uff1a\u4e39\u9ea6\u5236\u836f\u5de8\u5934\uff0c\u4e13\u6ce8\u4e8e\u7cd6\u5c3f\u75c5\u3001\u51cf\u80a5\u548c\u7f55\u89c1\u75c5\u836f\u7269\u7814\u53d1\uff0c\u662f\u964d\u7cd6\u836fOzempic\u548c\u51cf\u80a5\u836fWegovy\u7684\u5236\u9020\u5546\u3002\u4e1a\u52a1\u904d\u53ca170\u4e2a\u56fd\u5bb6\uff0c\u662f\u6b27\u6d32\u6700\u5927\u4f01\u4e1a\u4e4b\u4e00\uff0c\u5e02\u503c\u4e00\u5ea6\u8d85\u8fc7\u4e39\u9ea6GDP\u30025\u6708\uff0c\u56e0\u65d7\u8230\u51cf\u80a5\u836f\u9762\u4e34\u7684\u7ade\u4e89\u52a0\u5267\uff0c\u516c\u53f8\u5ba3\u5e03\u66f4\u6362CEO\u3002<\/li>\n
          • \u8865\u5145\u6570\u636e\uff1a\u8425\u6536462\u4ebf\u7f8e\u5143\uff1b\u6bdb\u5229\u6da6390\u4ebf\u7f8e\u5143\uff08\u7531\u4e39\u9ea6\u514b\u6717\u6362\u7b97\uff09\uff1b\u4e94\u5e74\u5e74\u5316\u56de\u62a5\u738719.56%\u3002<\/li>\n<\/ul>\n

            \u96c5\u57f9\u5b9e\u9a8c\u5ba4 (NYSE:ABT)<\/h2>\n
              \n
            • \u7b80\u4ecb\uff1a\u751f\u4ea7\u533b\u7597\u4fdd\u5065\u4ea7\u54c1\u548c\u8bbe\u5907\uff0c\u56db\u5927\u4e1a\u52a1\u677f\u5757\u5305\u62ec\u836f\u54c1\u3001\u8bca\u65ad\u4ea7\u54c1\u3001\u8425\u517b\u4ea7\u54c1\u548c\u533b\u7597\u5668\u68b0\u3002\u4e0e\u827e\u4f2f\u7ef4\u7c7b\u4f3c\uff0c\u662f\u80a1\u606f\u6295\u8d44\u8005\u7684\u9752\u7750\u5bf9\u8c61\uff0c\u5df2\u8fde\u7eed50\u591a\u5e74\u63d0\u9ad8\u80a1\u606f\uff0c\u8dfb\u8eab\u201c\u80a1\u606f\u738b\u201d\u884c\u5217\u3002<\/li>\n
            • \u8865\u5145\u6570\u636e\uff1a\u8425\u6536423\u4ebf\u7f8e\u5143\uff1b\u6bdb\u5229\u6da6237\u4ebf\u7f8e\u5143\uff1b\u4e94\u5e74\u5e74\u5316\u56de\u62a5\u73879.81%\u3002<\/li>\n<\/ul>\n

              \u963f\u65af\u5229\u5eb7 (NASDAQ:AZN)<\/h2>\n
                \n
              • \u7b80\u4ecb\uff1a\u745e\u5178\u516c\u53f8Astra AB\u548c\u82f1\u56fd\u516c\u53f8Zeneca\u4e8e1999\u5e74\u5408\u5e76\u6210\u7acb\uff0c\u603b\u90e8\u4f4d\u4e8e\u82f1\u56fd\u5251\u6865\u3002\u7814\u53d1\u5904\u65b9\u836f\u8986\u76d6\u5fc3\u8840\u7ba1\u75be\u75c5\u3001\u4ee3\u8c22\u7d0a\u4e71\u3001\u80be\u75c5\u53ca\u7f55\u89c1\u75c5\u7b49\u91cd\u5927\u75be\u75c5\u9886\u57df\u3002\u62e5\u670911\u4e2a\u7814\u53d1\u4e2d\u5fc3\u548c28\u4e2a\u751f\u4ea7\u57fa\u5730\uff0c\u4e1a\u52a1\u904d\u53ca130\u591a\u4e2a\u56fd\u5bb6\u3002<\/li>\n
              • \u8865\u5145\u6570\u636e\uff1a\u8425\u6536550\u4ebf\u7f8e\u5143\uff1b\u6bdb\u5229\u6da6448\u4ebf\u7f8e\u5143\uff1b\u4e94\u5e74\u5e74\u5316\u56de\u62a5\u73877.97%\u3002<\/li>\n<\/ul>\n

                \u8bfa\u534e (NYSE:NVS)<\/h2>\n
                  \n
                • \u7b80\u4ecb\uff1a\u745e\u58eb\u5236\u836f\u4f01\u4e1a\uff0c\u4ea7\u54c1\u5305\u62ec\u5fc3\u8870\u836fEntresto\u3001\u94f6\u5c51\u75c5\u836fCosentyx\u548c\u591a\u53d1\u6027\u786c\u5316\u75c7(MS)\u6cbb\u7597\u836fKesimpta\u7b49\u3002\u8be5\u516c\u53f8\u6b63\u5c06\u4eba\u5de5\u667a\u80fd(AI)\u6280\u672f\u878d\u5165\u4e1a\u52a1\uff0c\u4e0eViz.ai\u5408\u4f5c\u63d0\u4f9bAI\u8d4b\u80fd\u7684\u764c\u75c7\u60a3\u8005\u62a4\u7406\u3002<\/li>\n
                • \u8865\u5145\u6570\u636e\uff1a\u8425\u6536529\u4ebf\u7f8e\u5143\uff1b\u6bdb\u5229\u6da6399\u4ebf\u7f8e\u5143\uff1b\u4e94\u5e74\u5e74\u5316\u56de\u62a5\u738711.81%\u3002<\/li>\n<\/ul>\n

                  Intuitive Surgical (NASDAQ:ISRG)<\/h2>\n
                    \n
                  • \u7b80\u4ecb\uff1a\u751f\u4ea7\u673a\u5668\u4eba\u624b\u672f\u7cfb\u7edf\uff0c\u660e\u661f\u4ea7\u54c1da Vinci\u7cfb\u7edf\u572870\u591a\u4e2a\u56fd\u5bb6\u7528\u4e8e\u5fae\u521b\u624b\u672f\u3002\u516c\u53f8\u6b63\u62d3\u5c55\u6b27\u6d32\u4e1a\u52a1\uff0c2025\u5e741\u6708\u5ba3\u5e03\u8ba1\u5212\u5728\u610f\u5927\u5229\u3001\u897f\u73ed\u7259\u548c\u8461\u8404\u7259\u8bbe\u7acb\u76f4\u63a5\u4e1a\u52a1\u70b9\u3002<\/li>\n
                  • \u8865\u5145\u6570\u636e\uff1a\u8425\u653687\u4ebf\u7f8e\u5143\uff1b\u6bdb\u5229\u6da658\u4ebf\u7f8e\u5143\uff1b\u4e94\u5e74\u5e74\u5316\u56de\u62a5\u738723.64%\u3002<\/li>\n<\/ul>\n

                    \u9ed8\u514b (NYSE:MRK)<\/h2>\n
                      \n
                    • \u7b80\u4ecb\uff1a\u4ee5\u80bf\u7624\u4ea7\u54c1\u7ec4\u5408\u8457\u79f0\uff0c\u62e5\u6709\u5168\u7403\u6700\u7545\u9500\u836f\u7269Keytruda\u3002\u6b64\u5916\u8fd8\u751f\u4ea7\u7cd6\u5c3f\u75c5\u836f\u7269\u3001HPV\u75ab\u82d7\u548c\u6c34\u75d8\u75ab\u82d7\u3002\u8fd1\u671f\u8fdb\u884c\u4e86\u591a\u9879\u91cd\u5927\u6536\u8d2d\uff0c2024\u5e74\u6536\u8d2d\u4e86Harpoon Therapeutics\u3001Abceutics\u3001EyeBio\u548cModifi Biosciences\u3002<\/li>\n
                    • \u8865\u5145\u6570\u636e\uff1a\u8425\u6536639\u4ebf\u7f8e\u5143\uff1b\u6bdb\u5229\u6da6518\u4ebf\u7f8e\u5143\uff1b\u4e94\u5e74\u5e74\u5316\u56de\u62a5\u73872.59%\u3002<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"

                      \u6839\u636e\u6700\u65b0\u5e02\u573a\u6570\u636e\uff0c\u793c\u6765\u3001\u5f3a\u751f\u548c\u827e\u4f2f\u7ef4\u4f4d\u5c45\u5168\u7403\u533b\u7597\u5065\u5eb7\u9886\u57df\u5e02\u503c\u524d\u4e09\u7532\u3002\u5236\u836f\u4f01\u4e1a\u5728\u8be5\u9886\u57df\u5360\u636e\u4e3b\u5bfc\u5730\u4f4d\uff0c\u5728\u5e02\u503c\u6700\u5927\u7684 […]<\/p>\n","protected":false},"author":27,"featured_media":553414,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[820,513,455,925],"class_list":["post-578878","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-820","tag-513","tag-455","tag-925","sectors-life-science-zh-hans","locations-europe-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/578878","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=578878"}],"version-history":[{"count":2,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/578878\/revisions"}],"predecessor-version":[{"id":578892,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/578878\/revisions\/578892"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/553414"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=578878"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=578878"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=578878"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}